Promises
2 promises
Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Gujarat Fluorochemicals Limited — Q3 FY25
GFL reported a strong Q3 FY25 with revenue of INR 1,148 crores (+16% YoY), EBITDA of INR 294 crores (+43% YoY), and PAT of INR 126 crores (+58% YoY).
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
GFL reported a strong Q3 FY25 with revenue of INR 1,148 crores (+16% YoY), EBITDA of INR 294 crores (+43% YoY), and PAT of INR 126 crores (+58% YoY). EBITDA margin expanded to 26% (+500 bps YoY), driven by improved product mix in fluoropolymers and better pricing in refrigerants. The fluoropolymer segment is poised for growth following the exit of a legacy player and new qualifications, with full capacity utilization expected by end-FY26. The EV battery materials business continues to ramp up, with a cumulative CapEx plan of INR 6,000 crores by FY28 targeting ~2x asset turnover and ~25% EBITDA margins. Management remains confident despite potential IRA policy changes, citing strong customer demand. Key risk: R32 pricing volatility could impact the decision to invest in new capacity.
GFL ने तीसरी तिमाही में अच्छा प्रदर्शन किया। कमाई 1,148 करोड़ रुपये रही, जो पिछले साल से 16% ज्यादा है। कंपनी का मुनाफा 126 करोड़ रुपये रहा, जो 58% बढ़ा है। फ्लोरोपॉलीमर और रेफ्रिजरेंट्स की बिक्री बढ़ने से मुनाफा बढ़ा। एक पुरानी कंपनी के बाजार छोड़ने से फ्लोरोपॉलीमर सेगमेंट को फायदा होगा। इलेक्ट्रिक वाहन बैटरी का कारोबार भी बढ़ रहा है। कंपनी 2028 तक 6,000 करोड़ रुपये निवेश करेगी। प्रबंधन को भरोसा है, लेकिन R32 गैस की कीमत में उतार-चढ़ाव से निवेश पर असर पड़ सकता है।
Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
R32 pricing volatility could impact CapEx decision
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Fluoropolymer capacity utilization target
100%
by end-FY26
Management expects full capacity utilization in fluoropolymers by the end of FY26, driven by new qualifications and market demand.
R32 capacity addition
30,000 tons
new capacity
GFL plans to set up 30,000 tons of R32 capacity in phases, with first phase of 20,000 tons by Q4 FY26.
EV battery materials cumulative CapEx
INR 6,000 crores
by FY28
GFL remains committed to its cumulative CapEx plan of INR 6,000 crores by FY28 for the EV battery materials business.
Power cost savings
INR 150 crores/year
expected annual savings
Through renewable energy PPAs, GFL expects annual power cost savings of approximately INR 150 crores from FY26.
What Changed vs Last Quarter
NEW
Fluoropolymer full capacity utilization by end-FY26
Management expects to achieve full capacity utilization in the fluoropolymer segment by the end of FY26, driven by new product qualifications and market demand.
NEW
R32 capacity of 30,000 tons with first phase of 20,000 tons by Q4 FY26
GFL plans to set up 30,000 tons of R32 capacity in phases, with the first phase of 20,000 tons expected to be operational by Q4 FY26, at a CapEx of around INR 150 crores.
NEW
Power cost savings of ~INR 150 crores annually from FY26
Through renewable energy PPAs, GFL expects annual power cost savings of approximately INR 150 crores, reducing the weighted average power cost to around INR 4.5 per unit.
UPDATED
EV battery materials cumulative CapEx of INR 6,000 crores by FY28
GFL remains committed to its cumulative CapEx plan of INR 6,000 crores by FY28 for the EV battery materials business, targeting ~2x asset turnover and ~25% EBITDA margins at optimal utilization.
DROPPED
EV business: 2x asset turnover and 25% EBITDA margins at optimal utilization
Management reiterated guidance for GFCL EV to achieve 2x asset turnover and 25% EBITDA margins once capacities reach optimal utilization levels.
DROPPED
Commercial supplies from EV business to commence from Q4 FY25
Management expects initial commercial supplies of battery materials (salt, electrolyte, etc.) to start from Q4 FY25, following customer qualifications.
DROPPED
Substantial improvement in financials from Q4 FY25 onwards
Driven by fluoropolymer growth, refrigerant price recovery, and EV ramp-up, management expects a significant improvement in overall performance from Q4 FY25.
NEW RISK
R32 pricing volatility could impact CapEx decision
The decision to invest in R32 capacity is based on current pricing and demand-supply dynamics; a reversal in pricing could affect the viability of the investment.
NEW RISK
Potential revocation of IRA subsidies in the US
Changes in US policy, such as revocation of IRA subsidies, could impact the EV battery materials business, though management believes customer plans remain intact.
NEW RISK
Delays in domestic EV battery material ramp-up
The electrolyte business for the domestic market is experiencing hiccups as customers' plants face startup delays, which could slow revenue contributions.
NEW RISK
Chinese competition in fluoropolymers and refrigerants
Commodity-grade PTFE continues to face pricing pressure from low-cost Chinese suppliers, and additional MDC capacity in India could keep prices muted.
RISK GONE
Slower-than-expected EV business ramp-up
Battery materials qualification and commercial agreements may take longer than anticipated, delaying revenue and profitability from the EV segment.
RISK GONE
Chinese competition in commodity chemicals
Overcapacity in China continues to pressure pricing in bulk chemicals and fluorochemicals, potentially delaying margin recovery.
RISK GONE
Legacy player exit may not fully benefit GFL
Despite expectations, the redistribution of volumes from the exiting legacy player may not result in a proportional market share gain for GFL due to competition from other players.
RISK GONE
PFAS regulatory uncertainty
While management downplays the impact, evolving PFAS regulations globally could affect fluoropolymer demand or increase compliance costs.
🤫 Topics management stopped discussing
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management revised FY25 EBITDA guidance from 'better than FY23' to 'at par with FY23', indicating slower recovery.
Mentioned in Q1 FY25, Q3 FY24, Q4 FY24
LiPF6, electrolyte, and PVDF binder commercial supplies expected to commence from Q4 FY2025.
Mentioned in Q1 FY25, Q2 FY24, Q2 FY25
While management downplays the impact, evolving PFAS regulations globally could affect fluoropolymer demand or increase compliance costs.
Mentioned in Q3 FY24, Q4 FY24
Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.
Mentioned in Q1 FY24, Q3 FY24
Legacy player inventory may take longer to deplete than expected, delaying volume recovery.
Fast read
Guidance and risk preview
Management expects to achieve full capacity utilization in the fluoropolymer segment by the end of FY26, driven by new product qualifications and m...
The decision to invest in R32 capacity is based on current pricing and demand-supply dynamics; a reversal in pricing could affect the viability of...
View Risks →